More than a partner of C‐MYC oncoprotein in p53‐mutant breast and colon cancers, our previous[11] and present findings conclude that PDCD11 probably drives progression of a broad range of malignancies no matter p53 is wild‐typed or mutated (Figure S1, Supporting Information). Here, TP53 is linked to malignant colon neoplasm.